✦ LIBER ✦

PND21 Cost-Effectiveness Analysis of Antiepileptic Drugs in the Treatment of Lennox-Gastaut Syndrome

✍ Scribed by K.M. Clements; M. Skornicki; A.K. O'sullivan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness analysis of antiepile

✍ Clements, Karen M.; Skornicki, Michelle; O'Sullivan, Amy K. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 431 KB

PND6 Budget Impact Analysis of Antiepile

✍ M. Skornicki; K.M. Clements; A.K. O'Sullivan 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

PND18 RUFINAMIDE IN THE ADJUNCTIVE TREAT

✍ Y Yi; L Verdian; JP Jansen 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

PND10 COST EFFECTIVENESS ANALYSES OF RUF

✍ Benedict Á; PL Dale; G MacLaine; L Verdian 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

Clobazam in the treatment of Lennox-Gast

✍ Joan A. Conry; Yu-Tze Ng; Juliann M. Paolicchi; Lydia Kernitsky; Wendy G. Mitche 📂 Article 📅 2009 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 294 KB

Levetiracetam in the treatment of Lennox

✍ Emily C de los Reyes; Gregory B Sharp; Jane P Williams; Sue E Hale 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 35 KB